皮下黄体期孕酮补救可纠正冻融囊胚HRT周期中低孕酮患者的持续妊娠率
本研究为病例对照研究,纳入40例HRT冻融囊胚移植周期中孕酮补充第5天血清孕酮<8.75 ng/ml的患者,自第5天下午起每日皮下注射25 mg孕酮补救,并按年龄、BMI、既往尝试次数和移植囊胚数1:3匹配120例孕酮>8.75 ng/ml者为对照。补救组第5天孕酮较低(7.84±0.92 vs 15.32±5.02 ng/ml,P<0.001),补救后移植日平均孕酮达33.43±10.83 ng/ml,两组持续妊娠率相当。
要点
- HRT冻融囊胚移植前1天血清孕酮<8.75 ng/ml者,每日皮下25 mg孕酮补救可提升孕酮水平。
- 补救后移植日平均孕酮33.43±10.83 ng/ml,持续妊娠率与孕酮>8.75 ng/ml者相当。
- 补救组与对照组基线特征和胚胎学数据可比,主要结局为持续妊娠率。
核心结论
- 对HRT冻融囊胚移植周期中计划移植前1天(孕酮补充第6天)血清孕酮<8.75 ng/ml的患者,每日皮下25 mg孕酮补救似乎可挽救周期,持续妊娠率与孕酮>8.75 ng/ml者相当。
研究设计与样本
- 病例对照研究,纳入40例孕酮补充第5天血清孕酮<8.75 ng/ml并接受每日皮下25 mg孕酮补救的连续患者。
- 按年龄、BMI、既往尝试次数和移植囊胚数1:3匹配120例孕酮补充第5天血清孕酮>8.75 ng/ml者为对照。
- 主要结局指标为持续妊娠率(OPR)。
主要发现
- 补救组与对照组基线人口学特征和胚胎学数据可比。
- 孕酮补充第5天补救组平均血清孕酮低于对照组(7.84±0.92 vs 15.32±5.02 ng/ml;P<0.001)。
- 补救后冻融胚胎移植日(孕酮补充第6天)平均血清孕酮为33.43±10.83 ng/ml(范围14.61–82.64 ng/ml)。
- 补救组与对照组持续妊娠率相当。
关键数值与推荐
- 孕酮补充第5天血清孕酮<8.75 ng/ml为补救触发阈值。
- 补救方案为每日皮下注射25 mg孕酮,自孕酮补充第5天下午开始。
- 对照匹配条件为年龄、BMI、既往尝试次数和移植囊胚数。
临床怎么用
- HRT冻融囊胚移植周期中可监测孕酮补充第5天血清孕酮,低于8.75 ng/ml时考虑每日皮下25 mg孕酮补救。
- 补救后移植日血清孕酮可升至33.43±10.83 ng/ml,持续妊娠率与孕酮充足者相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Will luteal phase rescue with additional progesterone increase serum progesterone concentrations and improve reproductive outcomes in patients with low serum progesterone concentrations undergoing hormone replacement therapy (HRT) cycles? DESIGN: Case-control study including 40 consecutive patients with serum progesterone concentrations <8.75 ng/ml on the 5th day of progesterone supplementation who underwent rescue with a daily bolus of 25 mg s.c. progesterone, starting on the afternoon of the 5th day of progesterone administration. For every patient who underwent progesterone rescue, three patients matched by age, body mass index, number of previous attempts and number of blastocysts transferred, with serum progesterone concentration >8.75 ng/ml on the 5th day of progesterone administration served as controls (n = 120). The main outcome measure was ongoing pregnancy rate (OPR). RESULTS: Baseline demographic features and embryological data of the rescue and control groups were comparable. As expected, the mean serum progesterone concentration was lower in the rescue group on the 5th day of progesterone administration (7.84 ± 0.92 versus 15.32 ± 5.02 ng/ml; P < 0.001). Following rescue, the mean serum progesterone concentration on the day of vitrified-warmed embryo transfer (6th day of progesterone administration) was 33.43 ± 10.83 ng/ml (range 14.61-82.64 ng/ml), and the OPR of the rescue and control groups were comparable. CONCLUSIONS: In patients undergoing HRT vitrified-warmed blastocyst transfer with serum progesterone concentrations lower than 8.75 ng/ml 1 day prior to the scheduled embryo transfer (6th day of progesterone administration), additional supplementation with a 25 mg s.c. daily progesterone dose seems to rescue the cycle, resulting in OPR comparable to those of patients with serum progesterone >8.75 ng/ml.
引用
- Yarali H, Polat M, Mumusoglu S, et al. Subcutaneous luteal phase progesterone rescue rectifies ongoing pregnancy rates in hormone replacement therapy vitrified-warmed blastocyst transfer cycles. Reprod Biomed Online. 2021. PMID: 34016521. doi:10.1016/j.rbmo.2021.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。